Table 1. Characteristics of patients of the 145 CSF specimens admitted in the study.
Control group(n = 87) | BM group(n = 58) | |||
n | % | n | % | |
Age | ||||
O months to 12 months | 8 | (9.20) | 3 | (5.17) |
13 months to 5 years | 61 | (70.11) | 43 | (74.14) |
6 years to 14 years | 18 | (20.69) | 12 | (20.69) |
Sex | ||||
Male | 47 | (54.02) | 26 | (44.83) |
Female | 40 | (45.98) | 32 | (55.17) |
Aspect | ||||
Clear | 63 | (72.41) | 18 | (31.03) |
Low-cloudy | 3 | (3.45) | 7 | (12.07) |
Cloudy | 21 | (24.14) | 33 | (56.90) |
WBC count | ||||
≥10/µl | 28 | (32.18) | 46 | (79.31) |
<10/µl | 59 | (67.82) | 12 | (20.69) |
Glucose concentration | ||||
≤40 mg/dl | 43 | (49.43) | 43 | (74.14) |
>40 mg/dl | 44 | (50.57) | 15 | (25.86) |
Protein concentration | ||||
≥50 mg/dl | 32 | (36.78) | 51 | (87.93) |
<50 mg/dl | 55 | (63.22) | 7 | (12.07) |
Gram staining (n = 62) * | ||||
positive | 2 | (8.0) | 25 | (69.44) |
negative | 24 | (92.0) | 11 | (30.56) |
*For Gram staining n = 62. Gram staining was performed only for 26 specimens from control group and 36 specimens from BM group.